All In Biotech

Drug Trial Radar · NCT00002399

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

A Multicenter, Randomized, Double-Blind, Phase II Study to Evaluate the Safety, Tolerance and Efficacy of Multiple Doses of SCH 56592 Versus Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

500

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
Schering-PloughMerck & Co. (MRK)
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the safety and effectiveness of SCH 56592 with that of fluconazole in the treatment of OPC (a fungal infection of the throat) in HIV-positive patients.

Conditions

  • Candidiasis, Oral
  • HIV Infections

Interventions

  • PosaconazoleDrug

  • FluconazoleDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

53 sites in 18 countries. Site status is shown where the registry gives one.

  • Tucson Veterans Administration Med Ctr

    Tucson, Arizona

  • Northeast Arkansas Clinic

    Jonesboro, Arkansas

  • Miami Veterans Administration Med Ctr

    Miami, Florida

  • Mercy Hosp

    Miami, Florida

  • Ponce de Leon Med Ctr

    Atlanta, Georgia

  • Med College of Georgia

    Augusta, Georgia

  • Rush Med College / Rush Presbyterian - St Luke's Med Cen

    Chicago, Illinois

  • Wishard Hosp

    Indianapolis, Indiana

  • Wayne State Univ / Harper Hosp

    Detroit, Michigan

  • St Michaels Med Ctr

    Newark, New Jersey

  • Duke Univ Med Ctr

    Durham, North Carolina

  • Thomas Jefferson Univ / Division of Infectious Disease

    Philadelphia, Pennsylvania

  • Vanderbilt Univ Med Ctr

    Nashville, Tennessee

  • Univ of Texas Southwestern Med Ctr

    Dallas, Texas

  • Univ of Texas / Med School at Houston

    Houston, Texas

  • Univ of Texas Health Sciences Ctr

    San Antonio, Texas

  • Infections Ltd / Physicians Med Ctr

    Tacoma, Washington

  • Centro de Micologia / Facultad de Medicina UBA

    Buenos Aires, Argentina

  • Hosp Fernandez

    Buenos Aires, Argentina

  • CHU Saint Pierre

    Brussels, Belgium

  • St Paul's Hosp

    Vancouver, British Columbia, Canada

  • Victoria Gen Hosp

    Halifax, Nova Scotia, Canada

  • Montreal Gen Hosp

    Montreal, Quebec, Canada

  • Fundacion Arriaran

    Santiago, Chile

  • Avenida Lope de Vega Avenue esq/Calle Jose Amado Soler

    Ensanche Naco/ Santo Domingo, Dominican Republic

  • Faculty of Medicine / Dept of Internal Medicine

    Addis Ababa, Ethiopia

  • Hopital Raymond Poincare

    Garches, France

  • Hopital de La Conception

    Maseille, France

  • Hopital Guy de Chauliac Service des Maladies Infectieuses

    Montpellier, France

  • Service des Maladies Infectieuses Hopital de l Archet

    Nice, France

  • Hopital de l Institut Pasteur

    Paris, France

  • Hopital Rothchild

    Paris, France

  • Service des Maladies Infectieuses

    Tours, France

  • Service des Maladies Infectieuses

    Villejuif, France

  • Rheinische Friedrich Wilhelms Universitaet Medizinische

    Bonn, Germany

  • Universitaet Klinik Koln

    Cologne, Germany

  • Heinrich Heine Universitat

    Düsseldorf, Germany

  • Allgemeines Krankenhaus St Georg

    Hamburg, Germany

  • Universitaets Krankenhaus Eppendorf Medizinische Kernklinik

    Hamburg, Germany

  • Staedtisches Krankenhaus Kiel

    Kiel, Germany

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.